MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.
Elife. 2023 Nov 3;12:e83459. doi: 10.7554/eLife.83459.
Transsynaptic viral vectors provide means to gain genetic access to neurons based on synaptic connectivity and are essential tools for the dissection of neural circuit function. Among them, the retrograde monosynaptic ΔG-Rabies has been widely used in neuroscience research. A recently developed engineered version of the ΔG-Rabies, the non-toxic self-inactivating (SiR) virus, allows the long term genetic manipulation of neural circuits. However, the high mutational rate of the rabies virus poses a risk that mutations targeting the key genetic regulatory element in the SiR genome could emerge and revert it to a canonical ΔG-Rabies. Such revertant mutations have recently been identified in a SiR batch. To address the origin, incidence and relevance of these mutations, we investigated the genomic stability of SiR in vitro and in vivo. We found that "revertant" mutations are rare and accumulate only when SiR is extensively amplified in vitro, particularly in suboptimal production cell lines that have insufficient levels of TEV protease activity. Moreover, we confirmed that SiR-CRE, unlike canonical ΔG-Rab-CRE or revertant-SiR-CRE, is non-toxic and that revertant mutations do not emerge in vivo during long-term experiments.
转导性病毒载体提供了一种基于突触连接获得神经元遗传信息的手段,是解析神经回路功能的重要工具。其中,逆行单突触ΔG-Rabies 已广泛应用于神经科学研究。最近开发的一种经过工程改造的ΔG-Rabies 无毒自失活(SiR)病毒,允许对神经回路进行长期的基因操作。然而,狂犬病病毒的高突变率带来了一个风险,即针对 SiR 基因组中关键遗传调控元件的突变可能会出现,并使它恢复为典型的ΔG-Rabies。最近在一批 SiR 中发现了这种回复突变。为了解决这些突变的起源、发生率和相关性,我们研究了 SiR 在体外和体内的基因组稳定性。我们发现,“回复突变”是罕见的,只有当 SiR 在体外大量扩增时才会积累,特别是在 TEV 蛋白酶活性不足的非最佳生产细胞系中。此外,我们证实 SiR-CRE 与典型的ΔG-Rab-CRE 或回复突变 SiR-CRE 不同,是无毒的,并且在长期实验过程中不会在体内出现回复突变。